Direct Reprogramming of Murine Fibroblasts to Hematopoietic Progenitor Cells

Cell Reports

Volumn 9, Issue 5, 2014, Pages 1871-1884

  Batta, Kiran ^a   Florkowska, Magdalena ^a   Kouskoff, Valerie ^a   Lacaud, Georges ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR LMO2; TRANSCRIPTION FACTOR RUNX1C; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CLONE; CONTROLLED STUDY; DISEASE MODEL; EMBRYO CELL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ERYTHROID CELL; FIBROBLAST; GENE EXPRESSION; GENOME ANALYSIS; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; MEGAKARYOCYTE; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROTEIN DEPLETION; SOMATIC CELL; STROMA CELL; ADULT STEM CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIESIS; MOUSE; PHYSIOLOGY;

MURINAE;

ADULT STEM CELLS; ANIMALS; CELLS, CULTURED; CELLULAR REPROGRAMMING; FIBROBLASTS; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; MICE; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TRANSDUCTION, GENETIC;

EID: 84915791031     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.11.002     Document Type: Article

References (48)

1. Benito M., Parker J., Du Q., Wu J., Xiang D., Perou C.M., Marron J.S. Adjustment of systematic microarray data biases. Bioinformatics 2004, 20:105-114.
2. Blum B., Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 2008, 100:133-158.
3. Boisset J.-C., van Cappellen W., Andrieu-Soler C., Galjart N., Dzierzak E., Robin C. Invivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010, 464:116-120.
4. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
5. Chen M.J., Yokomizo T., Zeigler B.M., Dzierzak E., Speck N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457:887-891.
6. Doulatov S., Vo L.T., Chou S.S., Kim P.G., Arora N., Li H., Hadland B.K., Bernstein I.D., Collins J.J., Zon L.I., Daley G.Q. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 2013, 13:459-470.
7. Du Y., Wang J., Jia J., Song N., Xiang C., Xu J., Hou Z., Su X., Liu B., Jiang T., et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell 2014, 14:394-403.
8. Feng R., Desbordes S.C., Xie H., Tillo E.S., Pixley F., Stanley E.R., Graf T. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc. Natl. Acad. Sci. USA 2008, 105:6057-6062.
9. Ferkowicz M.J., Starr M., Xie X., Li W., Johnson S.A., Shelley W.C., Morrison P.R., Yoder M.C. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 2003, 130:4393-4403.
10. Ferreras C., Lancrin C., Lie-A-Ling M., Kouskoff V., Lacaud G. Identification and characterization of a novel transcriptional target of RUNX1/AML1 at the onset of hematopoietic development. Blood 2011, 118:594-597.
11. Gering M., Yamada Y., Rabbitts T.H., Patient R.K. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development 2003, 130:6187-6199.
12. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
13. Huang P., Zhang L., Gao Y., He Z., Yao D., Wu Z., Cen J., Chen X., Liu C., Hu Y., et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 2014, 14:370-384.
14. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
15. Jaffredo T., Gautier R., Eichmann A., Dieterlen-Lièvre F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 1998, 125:4575-4583.
16. Lancrin C., Sroczynska P., Stephenson C., Allen T., Kouskoff V., Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457:892-895.
17. Lancrin C., Sroczynska P., Serrano A.G., Gandillet A., Ferreras C., Kouskoff V., Lacaud G. Blood cell generation from the hemangioblast. J.Mol. Med. 2010, 88:167-172.
18. Li H., Collado M., Villasante A., Strati K., Ortega S., Cañamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
19. Loose M., Swiers G., Patient R. Transcriptional networks regulating hematopoietic cell fate decisions. Curr. Opin. Hematol. 2007, 14:307-314.
20. Loughran S.J., Kruse E.A., Hacking D.F., de Graaf C.A., Hyland C.D., Willson T.A., Henley K.J., Ellis S., Voss A.K., Metcalf D., et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 2008, 9:810-819.
21. McKinney-Freeman S., Cahan P., Li H., Lacadie S.A., Huang H.-T., Curran M., Loewer S., Naveiras O., Kathrein K.L., Konantz M., et al. The transcriptional landscape of hematopoietic stem cell ontogeny. Cell Stem Cell 2012, 11:701-714.
22. Mikkola H.K., Fujiwara Y., Schlaeger T.M., Traver D., Orkin S.H. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 2003, 101:508-516.
23. Mitjavila-Garcia M.T., Cailleret M., Godin I., Nogueira M.M., Cohen-Solal K., Schiavon V., Lecluse Y., Le Pesteur F., Lagrue A.H., Vainchenker W. Expression of CD41 on hematopoietic progenitors derived from embryonic hematopoietic cells. Development 2002, 129:2003-2013.
24. Nam Y.J., Song K., Luo X., Daniel E., Lambeth K., West K., Hill J.A., DiMaio J.M., Baker L.A., Bassel-Duby R., Olson E.N. Reprogramming of human fibroblasts toward a cardiac fate. Proc. Natl. Acad. Sci. USA 2013, 110:5588-5593.
25. Ohnishi K., Semi K., Yamamoto T., Shimizu M., Tanaka A., Mitsunaga K., Okita K., Osafune K., Arioka Y., Maeda T., et al. Premature termination of reprogramming invivo leads to cancer development through altered epigenetic regulation. Cell 2014, 156:663-677.
26. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
27. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
28. Pereira C.F., Chang B., Qiu J., Niu X., Papatsenko D., Hendry C.E., Clark N.R., Nomura-Kitabayashi A., Kovacic J.C., Ma'ayan A., et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 2013, 13:205-218.
29. Pereira C.F., Lemischka I.R., Moore K. 'From blood to blood': de-differentiation of hematopoietic progenitors to stem cells. EMBO J. 2014, 33:1511-1513.
30. Pimanda J.E., Göttgens B. Gene regulatory networks governing haematopoietic stem cell development and identity. Int. J. Dev. Biol. 2010, 54:1201-1211.
31. Pimanda J.E., Ottersbach K., Knezevic K., Kinston S., Chan W.Y.I., Wilson N.K., Landry J.-R., Wood A.D., Kolb-Kokocinski A., Green A.R., et al. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc. Natl. Acad. Sci. USA 2007, 104:17692-17697.
32. Ran D., Shia W.J., Lo M.C., Fan J.B., Knorr D.A., Ferrell P.I., Ye Z., Yan M., Cheng L., Kaufman D.S., Zhang D.E. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 2013, 121:2882-2890.
33. Riddell J., Gazit R., Garrison B.S., Guo G., Saadatpour A., Mandal P.K., Ebina W., Volchkov P., Yuan G.C., Orkin S.H., Rossi D.J. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014, 157:549-564.
34. Robb L., Elwood N.J., Elefanty A.G., Köntgen F., Li R., Barnett L.D., Begley C.G. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 1996, 15:4123-4129.
35. Robin C., Ottersbach K., Boisset J.-C., Oziemlak A., Dzierzak E. CD41 is developmentally regulated and differentially expressed on mouse hematopoietic stem cells. Blood 2011, 117:5088-5091.
36. Sandler V.M., Lis R., Liu Y., Kedem A., James D., Elemento O., Butler J.M., Scandura J.M., Rafii S. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 2014, 511:312-318.
37. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393.
38. Sroczynska P., Lancrin C., Pearson S., Kouskoff V., Lacaud G. Invitro differentiation of mouse embryonic stem cells as a model of early hematopoietic development. Methods Mol. Biol. 2009, 538:317-334.
39. Sturgeon C.M., Ditadi A., Clarke R.L., Keller G. Defining the path to hematopoietic stem cells. Nat. Biotechnol. 2013, 31:416-418.
40. Szabo E., Rampalli S., Risueño R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., Levadoux-Martin M., Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
41. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
42. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
43. Taoudi S., Bee T., Hilton A., Knezevic K., Scott J., Willson T.A., Collin C., Thomas T., Voss A.K., Kile B.T., et al. ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. Genes Dev. 2011, 25:251-262.
44. Tsai F.Y., Keller G., Kuo F.C., Weiss M., Chen J., Rosenblatt M., Alt F.W., Orkin S.H. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994, 371:221-226.
45. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
46. Wilson N.K., Foster S.D., Wang X., Knezevic K., Schütte J., Kaimakis P., Chilarska P.M., Kinston S., Ouwehand W.H., Dzierzak E., et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 2010, 7:532-544.
47. Zhao Z., Zuber J., Diaz-Flores E., Lintault L., Kogan S.C., Shannon K., Lowe S.W. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes Dev. 2010, 24:1389-1402.
48. Zovein A.C., Hofmann J.J., Lynch M., French W.J., Turlo K.A., Yang Y., Becker M.S., Zanetta L., Dejana E., Gasson J.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.